GLP-1 agonists are thought to flip that switch back to the OFF or at minimum, act as a dimmer switch to tone down the intensity of the ON signaling thereby reducing the production of inflammatory cytokines
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring hormone in the body, produced by the intestines
The bank reaches this conclusion by starting with OECD estimates that obesity reduces labor force output by approximately two percent in developed countries
Since the glucose-lowering effects of GIP have been shown to be impaired in patients with T2D, interest has focused on developing antidiabetic therapies based upon the actions of GLP-1 and GIP, the response to which remains intact. To continue reading Log in or register to continue reading
10 About Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the worlds largest biotechnology company and the global leader in in-vitro diagnostics